Angion’s HGF Mimetic Fails Second Phase II Study, But Not Shuttered Yet

 
• By Joseph Haas
  
Angion suffers second Phase II setback in two months with ANG-3777
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D